Will a left supraclavicular lymphoma show up on a contrast-enhanced MRI?
Yes—but MRI with contrast can show a left supraclavicular lymphoma, while FDG-PET/CT is the preferred and more accurate modality for detecting and staging lymphoma, which directly impacts morbidity, mortality, and quality of life. 1, 2
What MRI can do
- Contrast-enhanced neck MRI is recommended for an adult neck mass suspicious for malignancy; it detects and characterizes nodal masses (including supraclavicular) and their relationship to vessels and adjacent structures 1.
- Typical lymphoma nodes on MRI: homogeneous soft-tissue mass, low-to-intermediate T1, mildly high T2, moderate enhancement; DCE-MRI may show rapid enhancement with washout, though not specific for subtype 3, 4.
- Caveat: MRI (and CT) can miss small-volume disease in normal-sized nodes; size/appearance alone cannot exclude lymphoma—histology is required for diagnosis 1, 4.
What is better for outcomes
- PET-CT is the gold standard for staging FDG-avid lymphomas and should be obtained at baseline; it changes stage in 10%–30% and underpins response assessment, guiding therapy that affects survival and quality of life 2.
- For large B‑cell lymphoma and most Hodgkin lymphoma, PET-CT is central to staging and response-driven management decisions that influence prognosis 5, 6.
Practical algorithm
- If question is detection only: order contrast-enhanced neck MRI or CT to visualize a left supraclavicular mass; either is acceptable, MRI helps soft-tissue planes and neurovascular relationships 1.
- To optimize outcomes: immediately add whole-body FDG-PET/CT for staging and treatment planning in suspected FDG-avid lymphoma 2.
- Confirm diagnosis: perform ultrasound-guided fine-needle aspiration/core biopsy of the node for histopathology; imaging cannot establish subtype 1, 4.
- Pitfalls to avoid:
Bottom line for your patient